SCHEMBL4929949

SCHEMBL4929949

O=C(O)CNC(=O)c1cc(Br)c(OCc2cc(NC3CCC3)cc(C(F)(F)F)c2)c(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
MRGPRX4 Q96LA9 6/20 0.38
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RHOC P08134 1/20 0.35
RHOA P61586 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DHODH Q02127 1/20 0.35
TACR1 P25103 1/20 0.34
CCR2 P41597 3/20 0.34
MCHR1 Q99705 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
USP5 P45974 1/20 0.34
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933162 0.91 MRGPRX4 (0.42) MRGPRX4RHOCRHOACCR2USP5
SCHEMBL4931128 0.88 MEN1 (0.37) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL5717942 0.87 MRGPRX4 (0.39) THRATHRBMRGPRX4RHOCRHOA
SCHEMBL4535685 0.87 THRA (0.38) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4360211 0.86 MEN1 (0.39) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4934533 0.85 THRB (0.47) THRATHRBMRGPRX4S1PR1
SCHEMBL4929633 0.85 THRA (0.41) THRATHRBMRGPRX4RHOCRHOA
SCHEMBL4934248 0.85 THRA (0.44) THRATHRBMRGPRX4MEN1KMT2A
SCHEMBL4924564 0.84 THRA (0.45) THRATHRBMRGPRX4MEN1KMT2A
SCHEMBL4926344 0.84 THRA (0.60) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885MRGPRX4 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.